Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
New York Times
NYT
$12.2B
| $2.96M | ﹤0.01% |
57,818
-112,067
| -66% | -$5.27M |
|
|
NXRT
1827
NexPoint Residential Trust
NXRT
$623M
| $2.96M | ﹤0.01% |
74,934
-16,060
| -18% | -$564K |
|
|
EFOR
1828
Everforth Inc
EFOR
$1.26B
| $2.96M | ﹤0.01% |
33,554
-49,090
| -59% | -$4.69M |
|
|
EXAS
1829
CALL
DELISTED
Exact Sciences
EXAS
| $2.96M | ﹤0.01% |
70,000
-47,500
| -40% | -$2.61M |
|
1830
Denali Therapeutics
DNLI
$3.84B
| $2.95M | ﹤0.01% |
127,060
-24,500
| -16% | -$470K |
|
1831
Recursion Pharmaceuticals
RXRX
$1.76B
| $2.95M | ﹤0.01% |
393,154
+78,853
| +25% | +$688K |
|
|
UCB
1832
United Community Banks
UCB
$4.33B
| $2.94M | ﹤0.01% |
115,353
-86,117
| -43% | -$2.2M |
|
1833
Customers Bancorp
CUBI
$2.83B
| $2.94M | ﹤0.01% |
61,196
-17,875
| -23% | -$844K |
|
1834
CALL
IonQ
IONQ
$15.6B
| $2.94M | ﹤0.01% |
+417,500
| New | +$3.42M |
|
1835
Powell Industries
POWL
$7.7B
| $2.93M | ﹤0.01% |
61,362
+30,870
| +101% | +$1.61M |
|
1836
COPT Defense Properties
CDP
$4.29B
| $2.92M | ﹤0.01% |
116,719
-92,387
| -44% | -$2.22M |
|
1837
Spire
SR
$4.7B
| $2.92M | ﹤0.01% |
48,015
-75,811
| -61% | -$4.58M |
|
|
PDCO
1838
DELISTED
Patterson Companies, Inc.
PDCO
| $2.91M | ﹤0.01% |
120,809
-49,810
| -29% | -$1.25M |
|
|
UNIT
1839
Uniti Group
UNIT
$2.44B
| $2.91M | ﹤0.01% |
997,239
+768,367
| +336% | +$3.22M |
|
1840
Brighthouse Financial
BHF
$3.6B
| $2.9M | ﹤0.01% |
66,932
+1,334
| +2% | +$61.5K |
|
1841
Haemonetics
HAE
$3.88B
| $2.9M | ﹤0.01% |
35,063
-68,802
| -66% | -$6.05M |
|
1842
SoFi Technologies
SOFI
$24.1B
| $2.9M | ﹤0.01% |
438,719
-1,433,660
| -77% | -$10.1M |
|
1843
Exponent
EXPO
$3.29B
| $2.88M | ﹤0.01% |
30,263
-54,022
| -64% | -$4.87M |
|
1844
Camping World
CWH
$676M
| $2.88M | ﹤0.01% |
160,997
+14,757
| +10% | +$311K |
|
1845
Simpson Manufacturing
SSD
$8.08B
| $2.87M | ﹤0.01% |
17,024
-64,780
| -79% | -$11.3M |
|
|
ABPWW
1846
DELISTED
Abpro Holdings Warrant
ABPWW
| $2.87M | ﹤0.01% |
250,000
| – | – |
|
|
VMCAW
1847
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
| $2.85M | ﹤0.01% |
250,000
| – | – |
|
|
RERE
1848
ATRenew
RERE
$917M
| $2.85M | ﹤0.01% |
+1,202,137
| New | +$2.63M |
|
|
X
1849
DELISTED
US Steel
X
| $2.85M | ﹤0.01% |
75,361
-180,387
| -71% | -$6.88M |
|
|
INFA
1850
DELISTED
Informatica
INFA
| $2.85M | ﹤0.01% |
92,236
+12,145
| +15% | +$383K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.